Dear Friends of AHP,

If you are attending SupplySide this week, we invite you to join us for our AHP Networking Pub courtesy of our partners at Informa. This is a chance to learn about who AHP is, what we do, how we do it, and how we can support you in addressing your botanical quality control needs. Other topics worthy of discussion include House of Representatives bill HR 10150 Advancing Botanical Drug Act of 2026 and the September 9, 2026 Federal Register notification requesting comments on Advancing Botanical Drug Products. The commenting period for the Federal Register notification is soon approaching and stakeholders would be well-served to submit comments. There are many unknowns how such a category would affect access to botanical supplements. Please come and share your thoughts and ideas.

The formal public commenting period to the Federal Register notification closes November 3, 2026. The Federal Register notification can be accessed here: https://www.govinfo.gov/content/pkg/FR-2026-09-04/html/2026-18133.htm

The FDA notification of this initiative can be accessed here: https://www.fda.gov/drugs/resources-drugs/botanical-drug-products

HR 10150 can be accessed here: https://www.congress.gov/119/bills/hr10150/BILLS-119hr10150ih.pdf

For more information regarding both the Federal Register and HR 10150, you can access previous AHP News & Views here:

https://conta.cc/4jmxS9u

https://conta.cc/4ryAbZs

We hope to see you at the Networking Pub!

Sincere regards,

Roy Upton, President, American Herbal Pharmacopoeia

Founder, Global Alliance for Integrative Health & Medicine (GAIHM)